Tue, December 24, 2024
Fri, December 20, 2024
Thu, December 19, 2024
[ Thu, Dec 19th 2024 ]: WSPA
Limitless Fit-3 Mobility Exercises
Wed, December 18, 2024
Tue, December 17, 2024
[ Tue, Dec 17th 2024 ]: MSN
Gym wins fitness title
Mon, December 16, 2024
[ Mon, Dec 16th 2024 ]: Science Daily
Teen Health News
[ Mon, Dec 16th 2024 ]: Uber
Health & Fitness App 2024 Market Map
Sun, December 15, 2024
[ Sun, Dec 15th 2024 ]: Los Angeles Times
The Power of Resiliency

Ozempic before and after: 5 women get real about weight loss, side effects and cost


//health-fitness.news-articles.net/content/2024/ .. eal-about-weight-loss-side-effects-and-cost.html
Published in Health and Fitness on by Today   Print publication without navigation

Ozempic isn't approved for weight loss but that's a famous side effect, so some doctors have been prescribing it off-label for that purpose. People with obesity seeking to lose weight can also turn to Wegovy, which contains semaglutide — the same active ingredient as in Ozempic — and is approved for weight loss.

The article from Today.com discusses the transformative effects of Ozempic, a medication originally developed for managing type 2 diabetes, which has gained popularity for its weight loss benefits. It features before-and-after photos and testimonials from individuals who have used Ozempic, showcasing significant weight loss and improved health outcomes. Users report not only a reduction in weight but also benefits like lower blood sugar levels, reduced cravings, and an overall better quality of life. However, the article also touches on the side effects, such as nausea and the potential for "Ozempic face," where rapid weight loss can lead to sagging skin. Additionally, there's mention of the drug's high cost and the ongoing debate about its use for cosmetic weight loss versus medical necessity, highlighting the ethical considerations and the need for more long-term studies on its effects.

Read the Full Today Article at:
[ https://www.today.com/health/diet-fitness/ozempic-before-and-after-rcna99185 ]

Publication Contributing Sources